Prediction of Outcome in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib: Development and Validation of a Four-Factor Prognostic Model

Inhye E. Ahn,Xin Tian,David Ipe,Mei Cheng,Maher Albitar,L. Claire Tsao,Lei Zhang,Wanlong Ma,Sarah E. M. Herman,Erika M Gaglione,Susan Soto,James P Dean,Adrian Wiestner

Prediction of Outcome in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib: Development and Validation of a Four-Factor Prognostic Model

2020

Inhye E. Ahn
Xin Tian
David Ipe
Mei Cheng
Maher Albitar
L. Claire Tsao
Lei Zhang
Wanlong Ma
Sarah E. M. Herman
Erika M Gaglione
Susan Soto
James P Dean
Adrian Wiestner

PURPOSERandomized trials established the superiority of ibrutinib-based therapy over chemoimmunotherapy in chronic lymphocytic leukemia. Durability of progression-free survival (PFS) with ibrutinib...

Keywords:

in patient
Internal medicine
Ibrutinib
Oncology
Chronic lymphocytic leukemia
prognostic model
Chemoimmunotherapy
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations